Overview

CARM1 is an arginine methyltransferase which targets transcriptional coactivators, including SRC-1 and CBP, to regulate transcription at their cognate promoters. It has been shown to function as a coregulator for several members of the nuclear receptor superfamily.

Expression

CARM1 is broadly expressed in a variety of tissues, with peaks of expression in the central nervous system (corpus striatum, olfactory bulb, hypothalamus, pituitary), reproductive system (ovary, testis) and metabolic tissues (muscle, thyroid, aorta).
View the NURSA coregulator expression profiling dataset

Interactions New!

View the NURSA CARM1 HeLa cell protein interaction network in the pane below

Diseases

CARM1 has been shown to be overexpressed in prostate cancer and maps to a genomic location influencing circulating levels of homocysteine and therefore susceptibility to vascular diseases.

Phenotypes

Homozygous null deletion of CARM1 results in perinatal mortality and defects in protein methylation.

View the NURSA CARM1 Diseases and Phenotypes section in the pane below

	At a Glance
	Nomenclature Coactivator-associated arginine methyltransferase-1 (CARM1); Protein arginine N-methyltransferase 4 (PRMT4) Primary References Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW and Stallcup MR (1999) Regulation of transcription by a protein methyltransferase. Science 284, 2174-7. View Abstract \| View PubMed	At a Glance Orthologs Datasets Interactions Transcriptomics and Cistromics Diseases and Phenotypes Molecular Endocrinology Literature

My NURSA

Molecule Navigator

Receptors

Coregulators

Ligands

Select a range

1-E F-L M-Q R-Z

Select a specific molecule

Feedback

Questions? Comments?
Send Feedback Here

	About NURSA	Funding Institutions	Participating Institutions
	A message from the NURSA co-directors: To the nuclear receptor and coregulator scientific community, On behalf of its members, we would like to extend to you a warm welcome to the Nuclear Receptor Signaling Atlas (NURSA), a trans-NIH consortium organized in August 2002 and currently in its second phase (2007-2012) supported by the NIDDK, the NHLBI, and the NIEHS. Read more

© 2003 - 2010 NURSA, The Nuclear Receptor Signaling Atlas.